Skip to content

Investigating the effect of extract of rosa canina fruit on orthostatic hypotension

Investigating the effect of extract of rosa canina fruit on orthostatic hypotension in people with type 2 diabetes

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240726062545N1
Enrollment
60
Registered
2024-08-03
Start date
2024-09-05
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthostatic hypotension. Orthostatic hypotension

Interventions

Intervention 1: Intervention group: In addition to health recommendations such as drinking large amounts of fluids and increasing salt intake and following a diet, a 500 mg capsule containing water ex

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age above 18 years Suffering from type 2 diabetes Suffering from orthostatic hypotension based on internal specialist's diagnosis

Exclusion criteria

Exclusion criteria: Recent stroke or heart attack Having heart rhythm disorders uncontrolled blood pressure end-stage renal disease (ESRD) neuromuscular disease heart failure (CHF) HA1C level greater than 9 GFR less than 30 People who are treated with prazosin and tamsulosin

Design outcomes

Primary

MeasureTime frame
Orthostatic hypotension. Timepoint: Measurement of orthostatic hypotension at the beginning of the study and one month after the consumption of the rosa canina extract. Method of measurement: Use of sphygmomanometer.;Orthostatic Intolerance* Questionnaire (OIQ) score. Timepoint: Measurement of Orthostatic Intolerance* Questionnaire (OIQ) score at the beginning of the study and one month after consumption of Rosa canina extract. Method of measurement: Orthostatic Intolerance* Questionnaire (OIQ).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMorvarid Salamati

Yazd University of Medical Sciences

m.salamati78@gmail.com0003538224000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026